CAMBRIDGE, Mass.--(BUSINESS WIRE)--TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, today announced the formation of a Medical Advisory Board. The Medical Advisory Board, comprised of six expert clinicians and scientists in the oncology field, will advise the Company on its clinical development programs.
